US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.27 against a street estimate of 0.42 — a miss of 35.7%.
Analysts rate Embecta Corp a hold (1 buy, 3 hold, 1 sell out of 5) with an average price target of $4.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.45% |
| Vanguard Group Inc | 7.78% |
| Yacktman Asset Management Co | 6.19% |
| American Century Companies Inc | 5.80% |
| Vanguard Capital Management, LLC | 4.32% |
| State Street Corp | 4.29% |
| Deerfield Management Co | 4.27% |
| Jefferies Financial Group Inc | 3.97% |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Embecta Corp — free to start.
Google PlayApp StoreData updated 2026-08-05.